{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Cedars-Sinai
Cedars-Sinai
  • Sign In
  • Live Activities
  • On-Demand Activities
  • Grand Rounds and RSS
  • CE Planning Process
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Use My Cedars Login
Login with my CloudCME™ account
Enter your email and password to login:

*
*
Login

New to CloudCME? Create an Account:

Create New Account
Forgot Your Password?

Login Tips: 
PLEASE CREATE AN ACCOUNT IF:

• You have never attended a Cedars-Sinai CE activity
• OR You are a NEW member of the Cedars-Sinai Medical Staff since August 2023

If you do NOT meet either of the criteria above, please DO NOT CREATE AN ACCOUNT:

• If you do not know which email address is used for your account, please contact the Cedars-Sinai Office of CME.
• Accounts for existing Cedars-Sinai Medical Staff (prior to August 2023) use the primary email on file with the Medical Staff Office.

For ALL USERS: If you do not have the password for your account, click the "Forgot Your Password?" link.

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • ATC
  • BSN
  • CCC-SLP
  • CCLS
  • CPhT
  • CRNA
  • CRT
  • DC
  • DDS
  • DMD
  • DNAP
  • DNP
  • DO
  • DPM
  • LCGC
  • LCSW
  • LVN
  • MBBCh
  • MBBS
  • MD
  • MD, PhD
  • MPH
  • MS
  • MSN
  • MSW
  • None
  • NP
  • OT
  • Other
  • OTR/L
  • PA
  • PharmD
  • PhD
  • PsyD
  • PT
  • RD
  • RN
  • RN, BSN
  • RPh
  • RRT
  • RT
  • RVT
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

6th Annual New Therapeutics in Oncology: The Road to Personalized Medicine

  • Overview
  • Faculty
  • Schedule
  • Brochure
Add to Calendar 6th Annual New Therapeutics in Oncology: The Road to Personalized Medicine 11/3/2017 1:30:00 PM 11/4/2017 4:45:00 PM America/Los_Angeles For More Details: https://cedars.cloud-cme.com/course/courseoverview?EID=7587 Description: This important educational activity will provide guidance to front-line and oncology clinicians, oncology nurses, physicians, pharmacists, nurse practitioners, physician assistants and pharmacists with the most current information available about new agents in oncology and the translation of the latest research to their patients. The 6th Annual Experimental Therapeutics in Oncology: The Road to Persona... Harvey Morse Conference Center, Cedars-Sinai Medical Center false MM/DD/YYYY


Date & Location
Friday, November 3, 2017, 1:30 PM - Saturday, November 4, 2017, 4:45 PM PST, Harvey Morse Conference Center, Cedars-Sinai Medical Center

Target Audience
Specialties - Family / General Medicine, Internal Medicine, Oncology

Overview
This important educational activity will provide guidance to front-line and oncology clinicians, oncology nurses, physicians, pharmacists, nurse practitioners, physician assistants and pharmacists with the most current information available about new agents in oncology and the translation of the latest research to their patients. The 6th Annual Experimental Therapeutics in Oncology: The Road to Personalized Medicine conference will cover drug and treatment updates with a focus on new agents in breast cancer, GI malignancies, and head and neck cancer. The conference will also feature a mini-symposia that will cover various new clinical trials. 

Objectives
  1. Assess cancer immunotherapy treatments and their application in clinical practice based on a thorough understanding of how they work, their side effects and indications for use
  2. Evaluate emerging clinical data for new agents and evolving strategies for the treatment of breast cancer and develop individualized treatment plans for patients based upon an evaluation of efficacy and safety
  3. Evaluate clinical data and mechanism of action for newly approved drugs for the treatment of cancer
  4. Use AJCC or other appropriate staging in clinical practice, including appropriate prognostic indicators and evidence-based national guidelines for treatment planning
  5. Recognize and describe the mechanism of action, efficacy and side-effects of new treatment options for myeloma
  6. List and apply new treatment options for head and neck cancer

Registration
REGISTRATIONS ARE NOW CLOSED. ON-SITE REGISTRATION WILL BE AVAILABLE.

Refund Policy:

All cancellations must be submitted in writing and refunds will be subject to a $50 administrative charge. No refunds will be given after October 25, 2017. Please e-mail cancellation request to [email protected]. If you do not receive confirmation of your cancellation via e-mail, please call (310) 423-5548.



Accreditation

Cedars-Sinai Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Credit Designation Statement
Cedars-Sinai Medical Center designates this live activity for a maximum of 8.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 


Credits
AMA PRA Category 1 Credit(s)™ (MD, DO) (8.50 hours), Non-Physician AMA Attendance (8.50 hours)


Keywords: LIVEAMA



Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
David Chang, MD
Kite Pharma
Faculty
Salary-Kite Pharmaceuticals
Ezra Cohen, MD
UCSD
Faculty
Nothing to disclose
Barbara A. Conley, MD
National Cancer Institute
Faculty
Nothing to disclose
Robert A. Figlin, MD
Cedars-Sinai
Faculty
Morganna L. Freeman, DO
Cedars-Sinai Marina Del Rey Hospital
Faculty
Contracted Research-Immunocore
Marc T Goodman, PhD, MPH
3620694129
Faculty
Nothing to disclose
Faculty Photos
Omid Hamid, MD
The Angeles Clinic and Research Institute
Faculty
Consulting Fee-Amgen|Consulting Fee-Novartis AG|Consulting Fee-Roche|Consulting Fee-Bristol-Myers Squibb|Consulting Fee-Merck and Company, Inc.|Speakers Bureau-Amgen|Speakers Bureau-Bristol-Myers Squibb|Speakers Bureau-Genentech, Inc.|Speakers Bureau-Novartis AG|Contracted Research-AstraZeneca|Contracted Research-Bristol-Myers Squibb|Contracted Research-Celldex|Contracted Research-Genentech, Inc.|Contracted Research-Immunocore|Contracted Research-Incyte|Contracted Research-Merck and Company, Inc.|Contracted Research-Merck-Serono|Contracted Research-MedImmune|Contracted Research-Novartis AG|Contracted Research-Pfizer, Inc.|Contracted Research-Rinat|Contracted Research-Roche
Faculty Photos
Andrew E. Hendifar, MD
Cedars-Sinai
Faculty
Nothing to disclose
Edward Kim, MD
Levine Cancer Institute; Carolinas HealthCare System
Faculty
Consulting Fee-AstraZeneca|Consulting Fee-Celgene|Consulting Fee-Eli Lilly and Company|Consulting Fee-Boehringer Ingelheim Vetmedica GmbH
Razelle Kurzrock, MD
Medical College of Wisconsin
Faculty
Fees for Non-CE Services Received Directly from a Commercial Interest or its Agent-Dr. Kurzrock has research funding from Incyte, Genentech, Merck Serono, Pfizer, Sequenom, Foundation Medicine, and Guardant, as well as consultant fees from Sequenom, LOXO, and Actuate Therapeutics, and speaker fees from Roche, and an ownership interest in Curematch, Inc.
Nan Limvorasak, PharmD
Cedars-Sinai Medical Center
Faculty
Nothing to disclose
Heather McArthur, MD
Cedars-Sinai Medical Center
Faculty
Contracted Research-Bristol-Myers Squibb|Contracted Research-Eli Lilly and Company|Contracted Research-AstraZeneca|Contracted Research-Merck and Company, Inc.|Consulting Fee-Merck and Company, Inc.|Consulting Fee-Celgene|Consulting Fee-OBI|Consulting Fee-Spectrum Pharmaceuticals|Consulting Fee-Syndax Pharmaceuitcals|Consulting Fee-Roche|Consulting Fee-Peregrine|Consulting Fee-Calithera
Faculty Photos
Alain Mita, MD
Cedars-Sinai
Faculty
Faculty Photos
Monica M. Mita, MD
Cedars-Sinai
Faculty
Speakers Bureau-Genentech, Inc.
Faculty Photos
Ronald B. Natale, MD
Cedars-Sinai
Faculty
Steven Piantadosi, MD
Faculty
Nothing to disclose
Lawrence Piro, MD
The Angeles Clinic and Research Institute
Faculty
Speakers Bureau-TEVA
Faculty Photos
Edwin M Posadas, MD
Cedars-Sinai
Faculty
Speakers Bureau-Bayer Corporation|Contracted Research-Pfizer, Inc.|Contracted Research-Johnson and Johnson|Contracted Research-Merck and Company, Inc.
Faculty Photos
Barry E. Rosenbloom, MD
Cedars-Sinai Tower Hematology Oncology
Faculty
Nothing to disclose
Leanne Sakamoto, PharmD
Cedars-Sinai Medical Center
Faculty
Nothing to disclose
Richard B. Schwab, MD
UC San Diego Moores Cancer Center
Faculty
Nothing to disclose
Faculty Photos
Stephen Shiao, MD, PhD
Cedars-Sinai
Faculty
Nothing to disclose
Diane Simeone, MD
Perlmutter Cancer Center, NYU Langone Health
Faculty
Nothing to disclose

Friday, November 3, 2017
CME Disclosure Information and Supplemental Tool
1:30PM - 2:00PM
Lawrence Piro, MD
Ronald B. Natale, MD
Value-based therapeutics in oncology
2:00PM - 3:00PM
Edwin M Posadas, MD
Leanne Sakamoto, PharmD
Drug-Drug interactions in oncology
3:00PM - 3:30PM
Nan Limvorasak, PharmD
Immuno-oncology: Adverse events management
3:30PM - 4:00PM
Morganna L. Freeman, DO
Integration of immune therapies and radiation oncology
4:00PM - 4:30PM
Stephen Shiao, MD, PhD
Reception
4:30PM - 6:00PM
Saturday, November 4, 2017
Co-Chairs:
7:30AM - 8:10AM
Robert A. Figlin, MD
Razelle Kurzrock, MD
New Drugs Approved in 2017 and their mechanism of action
8:10AM - 8:40AM
Alain Mita, MD
Q & A
8:40AM - 8:50AM
Precision Promise
8:50AM - 9:10AM
Diane Simeone, MD
Redlich Lecture: Tapur
9:10AM - 9:30AM
Edward Kim, MD
NCI-Match
9:30AM - 9:50AM
Barbara A. Conley, MD
DART
9:50AM - 10:10AM
Razelle Kurzrock, MD
ISpy
10:10AM - 10:30AM
Richard B. Schwab, MD
Q & A
10:30AM - 10:40AM
Break
10:40AM - 11:00AM
Personalized medicine for GI malignancies: Harnessing Her2/Neu, BRAF and MSI
11:00AM - 11:40AM
Andrew E. Hendifar, MD
Q & A
11:40AM - 11:50AM
New therapeutic approaches for melanoma
11:50AM - 12:10PM
Omid Hamid, MD
Q & A
12:10PM - 12:30PM
Lunch
12:30PM - 1:25PM
Co-Chairs:
1:25PM - 1:30PM
Monica M. Mita, MD
Barry E. Rosenbloom, MD
KEYNOTE ADDRESS: T-Cell therapeutics (CME credit will not be provided for this talk)
1:30PM - 2:20PM
David Chang, MD
Q & A
2:20PM - 2:30PM
Updates in new therapeutics for hematological malignancies
2:30PM - 2:50PM
Q & A
2:50PM - 3:00PM
Break
3:00PM - 3:15PM
Fenmore Lecture: Head and neck cancer updates
3:15PM - 3:45PM
Ezra Cohen, MD
Q & A
3:45PM - 3:55PM
HPV-related malignancies
3:55PM - 4:15PM
Marc T Goodman, PhD, MPH
Q & A
4:15PM - 4:20PM
Integration of immune therapies in the treatment of breast cancer
4:20PM - 4:40PM
Heather McArthur, MD
Q & A
4:40PM - 4:45PM


CE Disclosure Form  | CE Application  | Privacy  |  Cedars-Sinai CME Homepage

Contact Us: [email protected]

        

© 2025 Cedars-Sinai. All Rights Reserved. A 501(c)(3) non-profit organization